AstraZeneca has inked a strategic partnership with local company Abu Dhabi-based G42 Healthcare to bolster pharmaceutical production.

It follows the Make it in the Emirates initiative, a strategy launched by the Ministry of Industry and Advanced Technology to boost the United Arab Emirates’ position as an attractive destination for both local and global investors and as a “global hub” for future industries.

The two companies outlined a multiyear process to manufacture innovative drugs in Abu Dhabi. By 2031, Abu Dhabi aims to double its manufacturing sector and expand its footprint in life sciences research and development, according to the department of health. Through other similar agreements, the government wants to create new high-skilled jobs.